| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 49.13B | 46.20B | 45.23B | 44.86B | 40.12B |
| Gross Profit | 12.55B | 11.90B | 11.42B | 11.89B | 10.25B |
| EBITDA | 6.71B | 6.40B | 6.38B | 6.14B | 4.25B |
| Net Income | 4.45B | 4.01B | 3.72B | 4.21B | 2.93B |
Balance Sheet | |||||
| Total Assets | 77.60B | 65.32B | 67.48B | 57.57B | 51.99B |
| Cash, Cash Equivalents and Short-Term Investments | 13.22B | 9.71B | 6.63B | 4.81B | 4.32B |
| Total Debt | 1.00B | 1.00B | 1.00B | 1.50B | 1.63B |
| Total Liabilities | 24.70B | 19.12B | 20.71B | 19.33B | 17.77B |
| Stockholders Equity | 52.90B | 46.20B | 46.77B | 38.24B | 34.22B |
Cash Flow | |||||
| Free Cash Flow | 5.06B | 4.82B | 2.86B | 1.15B | 1.25B |
| Operating Cash Flow | 7.61B | 6.07B | 4.83B | 3.87B | 2.94B |
| Investing Cash Flow | -2.40B | -1.31B | -1.98B | -2.81B | -1.69B |
| Financing Cash Flow | -1.78B | -1.77B | -1.12B | -691.00M | -965.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥43.46B | 9.64 | ― | 2.86% | 6.10% | 19.77% | |
78 Outperform | ¥29.10B | 9.99 | ― | 3.82% | 8.69% | 18.95% | |
77 Outperform | ¥45.39B | 8.51 | ― | 3.53% | -7.83% | 13.79% | |
65 Neutral | ¥94.45B | 21.35 | ― | 3.41% | 5.24% | -71.41% | |
65 Neutral | ¥82.42B | 11.45 | ― | 2.35% | 11.86% | 207.24% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | ¥18.99B | 15.81 | ― | 1.93% | 4.76% | -17.51% |